William D. Humphries - 22 Sep 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
22 Sep 2023
Net transactions value
+$9,091
Form type
4
Filing time
22 Sep 2023, 16:35:39 UTC
Previous filing
07 Jul 2023
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Options Exercise $9,091 +22,727 +80% $0.4000 51,040 22 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Options Exercise $0 -22,727 -100% $0.000000* 0 22 Sep 2023 Common Stock 22,727 $0.4000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.